Oncology & Cancer
Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt ...
Jan 6, 2012
0
0
